for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Panacea Biotec Limited

PNCA.NS

Latest Trade

130.50INR

Change

-2.15(-1.62%)

Volume

45,578

Today's Range

130.00

 - 

137.00

52 Week Range

110.00

 - 

215.95

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Latest Developments

Panacea Biotec Gets $24.32 Mln Award Of Pentavalent Vaccine From U.N. Agencies

Dec 19 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::PANACEA BIOTEC LTD SAYS GETS $24.32 MILLION AWARD OF PENTAVALENT VACCINE FROM U.N. AGENCIES.

India's Panacea Biotec Sept-Qtr Consol Net Loss After Tax Widens

Nov 14 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::SEPT-QUARTER CONSOL NET LOSS AFTER TAX 21.8 MILLION RUPEES VERSUS LOSS OF 9.4 MILLION RUPEES YEAR AGO.SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 1.25 BILLION RUPEES VERSUS 1.2 BILLION RUPEES YEAR AGO.

India's Panacea Biotec June-Qtr Consol Net Loss After Tax Narrows

Aug 12 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::JUNE QUARTER CONSOL NET LOSS AFTER TAX 265.1 MILLION RUPEES VERSUS LOSS OF 338.3 MILLION RUPEES YEAR AGO.JUNE QUARTER CONSOL REVENUE FROM OPERATIONS 1.26 BILLION RUPEES VERSUS 992.8 MILLION RUPEES YEAR AGO.

Panacea Biotec Gets Azacitidine USFDA Approval For U.S. Market

May 20 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::PANACEA BIOTEC RECEIVES AZACITIDINE USFDA APPROVAL FOR US MARKET.

Panacea Biotec Says India Resurgence Fund To Invest Up To $144 Mln In Co

April 8 (Reuters) - PANACEA BIOTEC LTD <PNCA.NS>: :INDIA RESURGENCE FUND ANNOUNCED INVESTMENT OF UP TO $144 MILLION IN CO.IINVESTMENT PROCEEDS WILL BE USED FOR, AMONG OTHERS, ONE-TIME SETTLEMENT WITH EXISTING LENDERS.INVESTMENT IS STRUCTURED VIA NCDS OF UP TO 8.64 BILLION RUPEES, SUBSCRIPTION AMOUNT OF 320 MILLION RUPEES FOR SHARE WARRANTS.SUBJECT TO EXERCISE OF WARRANTS, INDIARF, AFFILIATES, TO COLLECTIVELY OWN 10.4% STAKE CO.

Panacea Biotec Approves One Time Settlement With Consortium Of Lenders Of Co

Feb 26 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::APPROVED ONE TIME SETTLEMENT WITH CONSORTIUM OF LENDERS OF CO.APPROVED DEMERGER OF REAL ESTATE BUSINESS OF COMPANY.APPROVED RAISING OF FUNDS THROUGH ISSUE OF NCDS AGGREGATING UPTO 8.64 BILLION RUPEES.APPROVED RAISING OF FUNDS VIA ISSUE OF WARRANTS BY ISSUING UP TO 7.1 MILLION WARRANTS OF 180 RUPEES EACH.APPROVED TRANSFER OF PHARMACEUTICAL FORMULATIONS BUSINESS OF CO TO UNIT OF CO AS A GOING CONCERN.

India's Panacea Biotec Posts Dec-Qtr Loss

Feb 14 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::DEC QUARTER NET LOSS 230.2 MILLION RUPEES VERSUS LOSS OF 97.1 MILLION RUPEES YEAR AGO.DEC QUARTER REVENUE FROM OPERATIONS 1.14 BILLION RUPEES VERSUS 1.52 BILLION RUPEES YEAR AGO.

India's Panacea Biotec Posts Sept-Qtr Loss

Nov 14 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::SEPT QUARTER NET LOSS 974.9 MILLION RUPEES VERSUS LOSS OF 56.3 MILLION RUPEES YEAR AGO.SEPT QUARTER REVENUE FROM OPERATIONS 1.19 BILLION RUPEES VERSUS 1.53 BILLION RUPEES YEAR AGO.

Panacea Biotec Gets Shareholders' Nod For Reappointment Of Rajesh Jain As MD

Oct 1 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF SOSHIL KUMAR JAIN AS WHOLE-TIME DIRECTOR DESGINATED AS CHAIRMAN.GETS SHAREHOLDERS' NOD FOR REAPPOINTMENT OF RAJESH JAIN AS MD.GETS SHAREHOLDERS' NOD FOR RE-APPOINTMENT OF SANDEEP JAIN AS JOINT MD.

Panacea Biotec Enters Into Agreement With Natco Pharma And Breckenridge Pharma

Aug 27 (Reuters) - Panacea Biotec Ltd <PNCA.NS>::SAYS ENTERED INTO TRIPARTITE AGREEMENT WITH NATCO PHARMA AND BRECKENRIDGE PHARMACEUTICAL.AGREEMENT FOR THE MANUFACTURE AND SUPPLY OF AZACITIDINE INJECTION FOR THE U.S. MARKET.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up